Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MGD007 |
Synonyms | |
Therapy Description |
MGD007 is a bispecific monoclonal antibody binds to and crosslinks CD3-positive T-cells and gpA33-positive tumor cells to promote antitumor immunity (PMID: 29866746). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MGD007 | MGD007 is a bispecific monoclonal antibody binds to and crosslinks CD3-positive T-cells and gpA33-positive tumor cells to promote antitumor immunity (PMID: 29866746). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02248805 | Phase I | MGD007 | Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma | Completed | USA | 0 |